190 related articles for article (PubMed ID: 19773112)
1. Exploration of Shh and BMP paracrine signaling in a prostate cancer xenograft.
Shaw A; Gipp J; Bushman W
Differentiation; 2010 Jan; 79(1):41-7. PubMed ID: 19773112
[TBL] [Abstract][Full Text] [Related]
2. Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.
Pham LK; Liang M; Adisetiyo HA; Liao CP; Cohen MB; Tahara SM; Frenkel B; Kasahara N; Roy-Burman P
Endocr Relat Cancer; 2013 Dec; 20(6):861-74. PubMed ID: 24042462
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog signaling promotes prostate xenograft tumor growth.
Fan L; Pepicelli CV; Dibble CC; Catbagan W; Zarycki JL; Laciak R; Gipp J; Shaw A; Lamm ML; Munoz A; Lipinski R; Thrasher JB; Bushman W
Endocrinology; 2004 Aug; 145(8):3961-70. PubMed ID: 15132968
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation.
Zunich SM; Valdovinos M; Douglas T; Walterhouse D; Iannaccone P; Lamm ML
Mol Cancer; 2012 Jul; 11():30. PubMed ID: 22559324
[TBL] [Abstract][Full Text] [Related]
5. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
[TBL] [Abstract][Full Text] [Related]
6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
7. Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells.
Shigemura K; Huang WC; Li X; Zhau HE; Zhu G; Gotoh A; Fujisawa M; Xie J; Marshall FF; Chung LW
Prostate; 2011 Dec; 71(16):1711-22. PubMed ID: 21520153
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression.
Yuen HF; McCrudden CM; Grills C; Zhang SD; Huang YH; Chan KK; Chan YP; Wong ML; Law S; Srivastava G; Fennell DA; Dickson G; El-Tanani M; Chan KW
Cancer Sci; 2012 Jun; 103(6):1145-54. PubMed ID: 22364398
[TBL] [Abstract][Full Text] [Related]
9. Paracrine sonic hedgehog signalling by prostate cancer cells induces osteoblast differentiation.
Zunich SM; Douglas T; Valdovinos M; Chang T; Bushman W; Walterhouse D; Iannaccone P; Lamm ML
Mol Cancer; 2009 Mar; 8():12. PubMed ID: 19254376
[TBL] [Abstract][Full Text] [Related]
10. Serum regulation of Id1 expression by a BMP pathway and BMP responsive element.
Lewis TC; Prywes R
Biochim Biophys Acta; 2013 Oct; 1829(10):1147-59. PubMed ID: 23948603
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.
Nishimori H; Ehata S; Suzuki HI; Katsuno Y; Miyazono K
J Biol Chem; 2012 Jun; 287(24):20037-46. PubMed ID: 22532569
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
Haudenschild DR; Palmer SM; Moseley TA; You Z; Reddi AH
Cancer Res; 2004 Nov; 64(22):8276-84. PubMed ID: 15548695
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling.
Wahdan-Alaswad RS; Song K; Krebs TL; Shola DT; Gomez JA; Matsuyama S; Danielpour D
Cancer Res; 2010 Nov; 70(22):9106-17. PubMed ID: 21062988
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid induces prostatic bud formation.
Vezina CM; Allgeier SH; Fritz WA; Moore RW; Strerath M; Bushman W; Peterson RE
Dev Dyn; 2008 May; 237(5):1321-33. PubMed ID: 18393306
[TBL] [Abstract][Full Text] [Related]
15. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
[TBL] [Abstract][Full Text] [Related]
16. BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype.
Darby S; Cross SS; Brown NJ; Hamdy FC; Robson CN
J Pathol; 2008 Feb; 214(3):394-404. PubMed ID: 18072288
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
18. Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling.
Jia Y; Wang Z; Zang A; Jiao S; Chen S; Fu Y
Int J Oncol; 2016 May; 48(5):2079-86. PubMed ID: 26984046
[TBL] [Abstract][Full Text] [Related]
19. Modulation of BMP signaling by Noggin is required for the maintenance of palatal epithelial integrity during palatogenesis.
He F; Xiong W; Wang Y; Matsui M; Yu X; Chai Y; Klingensmith J; Chen Y
Dev Biol; 2010 Nov; 347(1):109-21. PubMed ID: 20727875
[TBL] [Abstract][Full Text] [Related]
20. BMP signaling regulates PGC numbers and motility in organ culture.
Dudley BM; Runyan C; Takeuchi Y; Schaible K; Molyneaux K
Mech Dev; 2007 Jan; 124(1):68-77. PubMed ID: 17112707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
